Table 2 Univariate clinical correlates of suicidality in patients with anorexia nervosa, restricting type

Age of ED onset in years, Mdn (Q1,Q3)

13.7

(12.5,14.9)

14.0

(12.9,15.1)

-1.4

4013.0

0.167

0.18

Duration of illness, month, M ± SD

15.2

 ± 13.7

10.7

 ± 10.1

60.4

-2.2

0.035

0.42

BMI percentiles at hospital admission, Mdn (Q1,Q3)

1.0

(1.0,1.0)

1.0

(1.0,1.0)

-0.6

4570.5

0.577

0.05

Kgs < 1^st BMI percentile, Mdn (Q1,Q3)

0.0

(-2.3,0.0)

-1.2

(-4.4,0.0)

-3.2

3356.5

0.001

0.41

Weight change in kg/week

0.5

(0.3,0.7)

0.6

(0.4,0.7)

-2.1

3774.0

0.037

0.27

Psychiatric comorbidities, average number, Mdn (Q1,Q3)

1.0

(0.0,1.0)

0.0

(0.0,1.0)

-5.1

2781.5

 < 0.001

0.60

Psychiatric comorbidities, at least one, n (%)

35

(71.4)

61

(31.6)

1

25.9

 < 0.001

0.33

Affective disorders, at least one, n (%)

21

(42.9)

40

(20.7)

1

10.2

0.001

0.21

 Depressive episode

12

(24.5)

25

(13.0)

1

4.0

0.045

0.13

 Persistent affective disorder

10

(20.4)

16

(8.3)

1

6.0

0.014

0.16

Anxiety disorders, at least one, n (%)

5

(10.2)

3

(1.6)

1

6.6

0.010

0.19

 Phobia

3

(6.1)

3

(1.6)

1

1.7

0.099

0.12

 Panic disorder

2

(4.1)

0

(0.0)

1

3.7

0.040

0.18

 Mixed anxiety and depression

1

(2.0)

0

(0.0)

1

0.6

0.202

0.13

 Generalized anxiety disorder

1

(2.0)

0

(0.0)

1

0.6

0.202

0.13

Post-traumatic stress disorder

0

(0.0)

1

(0.5)

1

0.0

1.000

0.03

Obsessive–compulsive disorder

9

(18.4)

14

(7.3)

1

4.4

0.036

0.15

Personality disorders traits, n (%)

7

(14.3)

6

(3.1)

1

7.5

0.006

0.20

 Borderline

2

(4.1)

1

(0.5)

1

1.7

0.105

0.13

 Anankastic

1

(2.0)

3

(1.6)

1

0.0

1.000

0.02

 Histrionic

3

(6.1)

0

(0.0)

1

7.5

0.008

0.22

 Combined

1

(2.0)

1

(0.5)

1

0.0

0.356

0.07

 Anxious

0

(0.0)

1

(0.5)

1

0.0

1.000

0.03

Family psychopathology present

35

(71.4)

120

(62.2)

1

1.5

0.228

0.08

Suicide (attempt) environment, n (%)

8

(16.3)

16

(8.3)

1

2.0

0.158

0.11

History of childhood abuse, n (%)

3

(6.1)

12

(6.2)

1

0.0

1.000

0.00

 Physical abuse

2

(4.1)

5

(2.6)

1

0.0

0.632

0.07

 Emotional abuse

0

(0.0)

5

(2.6)

1

0.3

0.586

0.04

 Sexual abuse

1

(2.0)

2

(1.0)

1

0.0

0.494

0.04

NSSI, average number, Mdn (Q1,Q3)

0

(0.0,0.0)

0

(0.0,0.0)

-4.5

3840.5

 < 0.001

0.26

NSSI, at least one, n (%)

12

(24.5)

8

(4.1)

1

18.7

 < 0.001

0.30

Psychotropic drugs, average number, Mdn (Q1,Q3)

0.0

(0.0,1.0)

0.0

(0.0,0.0)

-2.3

3992.5

0.022

0.22

Psychiatric drugs, at least one, n (%)

17

(34.7)

39

(20.2)

1

4.6

0.032

0.14

 Antidepressants

12

(24.5)

24

(12.4)

1

4.5

0.034

0.14

 Antipsychotics

10

(20.4)

22

(11.4)

1

2.8

0.096

0.11

 Anxiolytics

1

(2.0)

1

(0.5)

1

0.0

0.365

0.07